# Modular Medical, Inc.: financial statements, quarterly

MODD · Nasdaq · CIK 1074871 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/modd.md) · [Financials](/companies/modd/financials.md) · [Filings](/companies/modd/filings.md) · [Insiders](/companies/modd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/modd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | [3,159](/filings/0001213900-24-098418.md) | [3,838](/filings/0001213900-25-013462.md) | [3,115 d](/filings/0001213900-25-055793.md) | [3,205](/filings/0001213900-25-076594.md) | [3,702](/filings/0001213900-25-110819.md) | [3,853](/filings/0001213900-26-017262.md) | [3,937 d](/filings/0001213900-26-073223.md) | [5,134](/filings/0001213900-26-090301.md) | [5,593](/filings/0001213900-25-110819.md) | [5,405](/filings/0001213900-26-017262.md) | [3,841 d](/filings/0001213900-26-073223.md) | [4,371](/filings/0001213900-26-090301.md) |
| Operating income | $k | [(4,190)](/filings/0001213900-24-098418.md) | [(5,269)](/filings/0001213900-25-013462.md) | [(4,319) d](/filings/0001213900-25-055793.md) | [(4,220)](/filings/0001213900-25-076594.md) | [(4,996)](/filings/0001213900-25-110819.md) | [(4,854)](/filings/0001213900-26-017262.md) | [(4,978) d](/filings/0001213900-26-073223.md) | [(6,804)](/filings/0001213900-26-090301.md) | [(7,829)](/filings/0001213900-25-110819.md) | [(7,244)](/filings/0001213900-26-017262.md) | [(5,683) d](/filings/0001213900-26-073223.md) | [(6,538)](/filings/0001213900-26-090301.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [2.0](/filings/0001213900-24-098418.md) | [0.0 d](/filings/0001213900-25-013462.md) | [0.0 d](/filings/0001213900-25-055793.md) | not reported | [2.0](/filings/0001213900-25-110819.md) | [0.0 d](/filings/0001213900-26-017262.md) | [0.0 d](/filings/0001213900-26-073223.md) | not reported | [2.0](/filings/0001213900-25-110819.md) | [0.0 d](/filings/0001213900-26-017262.md) | [0.0 d](/filings/0001213900-26-073223.md) | not reported |
| Net income | $k | [(4,183)](/filings/0001213900-25-013462.md) | [(5,269)](/filings/0001213900-25-013462.md) | [(4,281) d](/filings/0001213900-25-055793.md) | [(4,137)](/filings/0001213900-26-017262.md) | [(4,956)](/filings/0001213900-26-017262.md) | [(4,804)](/filings/0001213900-26-017262.md) | [(4,927) d](/filings/0001213900-26-073223.md) | [(6,702)](/filings/0001213900-26-090301.md) | [(7,790)](/filings/0001213900-26-017262.md) | [(7,360)](/filings/0001213900-26-017262.md) | [(6,390) d](/filings/0001213900-26-073223.md) | [(6,486)](/filings/0001213900-26-090301.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001213900-24-098418.md) | [(0.23)](/filings/0001213900-25-013462.md) | not reported | [(0.12)](/filings/0001213900-25-076594.md) | [(0.14)](/filings/0001213900-25-110819.md) | [(0.13)](/filings/0001213900-26-017262.md) | not reported | [(3.70)](/filings/0001213900-26-090301.md) | [(0.14)](/filings/0001213900-25-110819.md) | [(0.11)](/filings/0001213900-26-017262.md) | not reported | [(1.19)](/filings/0001213900-26-090301.md) |
| Basic EPS | $ per share | [(0.19)](/filings/0001213900-24-098418.md) | [(0.23)](/filings/0001213900-25-013462.md) | not reported | [(0.12)](/filings/0001213900-25-076594.md) | [(0.14)](/filings/0001213900-25-110819.md) | [(0.13)](/filings/0001213900-26-017262.md) | not reported | [(3.70)](/filings/0001213900-26-090301.md) | [(0.14)](/filings/0001213900-25-110819.md) | [(0.11)](/filings/0001213900-26-017262.md) | not reported | [(1.19)](/filings/0001213900-26-090301.md) |

- Revenue: not reported
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.3](/filings/0001213900-23-086248.md) | [2.0](/filings/0001213900-24-013348.md) | [9.2](/filings/0001213900-25-055793.md) | not reported | not reported | [7.0](/filings/0001213900-25-013462.md) | [13.1](/filings/0001213900-26-073223.md) | [7.5](/filings/0001213900-25-076594.md) | [5.3](/filings/0001213900-25-110819.md) | [2.9](/filings/0001213900-26-017262.md) | [6.9](/filings/0001213900-26-090301.md) | [3.9](/filings/0001213900-26-090301.md) |
| Current assets | $m | [6.5](/filings/0001213900-23-086248.md) | [2.3](/filings/0001213900-24-013348.md) | [9.7](/filings/0001213900-25-055793.md) | [5.4](/filings/0001213900-24-068407.md) | [4.2](/filings/0001213900-24-098418.md) | [7.3](/filings/0001213900-25-013462.md) | [13.5](/filings/0001213900-26-073223.md) | [8.3](/filings/0001213900-25-076594.md) | [5.9](/filings/0001213900-25-110819.md) | [3.5](/filings/0001213900-26-017262.md) | [7.5](/filings/0001213900-26-090301.md) | [4.8](/filings/0001213900-26-090301.md) |
| Total assets | $m | [10.1](/filings/0001213900-23-086248.md) | [6.2](/filings/0001213900-24-013348.md) | [13.8](/filings/0001213900-25-055793.md) | [10.1](/filings/0001213900-24-068407.md) | [8.8](/filings/0001213900-24-098418.md) | [12.1](/filings/0001213900-25-013462.md) | [18.7](/filings/0001213900-26-073223.md) | [14.2](/filings/0001213900-25-076594.md) | [13.0](/filings/0001213900-25-110819.md) | [10.3](/filings/0001213900-26-017262.md) | [14.8](/filings/0001213900-26-090301.md) | [12.3](/filings/0001213900-26-090301.md) |
| Current liabilities | $m | [1.1](/filings/0001213900-23-086248.md) | [1.4](/filings/0001213900-24-013348.md) | [1.5](/filings/0001213900-25-055793.md) | [1.3](/filings/0001213900-24-068407.md) | [1.2](/filings/0001213900-24-098418.md) | [1.4](/filings/0001213900-25-013462.md) | [1.3](/filings/0001213900-26-073223.md) | [2.1](/filings/0001213900-25-076594.md) | [4.0](/filings/0001213900-25-110819.md) | [2.2](/filings/0001213900-26-017262.md) | [1.9](/filings/0001213900-26-090301.md) | [1.5](/filings/0001213900-26-090301.md) |
| Total liabilities | $m | [2.1](/filings/0001213900-23-086248.md) | [2.4](/filings/0001213900-24-013348.md) | [2.3](/filings/0001213900-25-055793.md) | [2.1](/filings/0001213900-24-068407.md) | [1.9](/filings/0001213900-24-098418.md) | [1.9](/filings/0001213900-25-013462.md) | [1.7](/filings/0001213900-26-073223.md) | [2.3](/filings/0001213900-25-076594.md) | [4.2](/filings/0001213900-25-110819.md) | [4.4](/filings/0001213900-26-017262.md) | [1.9](/filings/0001213900-26-090301.md) | [1.5](/filings/0001213900-26-090301.md) |
| Shareholders' equity | $m | [7.9](/filings/0001213900-25-013462.md) | [3.8](/filings/0001213900-25-013462.md) | [11.5](/filings/0001213900-26-073223.md) | [8.0](/filings/0001213900-26-017262.md) | [6.9](/filings/0001213900-26-017262.md) | [10.3](/filings/0001213900-26-017262.md) | [17.1](/filings/0001213900-26-090301.md) | [11.8](/filings/0001213900-26-090301.md) | [8.8](/filings/0001213900-26-017262.md) | [5.9](/filings/0001213900-26-017262.md) | [13.0](/filings/0001213900-26-090301.md) | [10.8](/filings/0001213900-26-090301.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,277) d](/filings/0001213900-24-098418.md) | [(3,965) d](/filings/0001213900-25-013462.md) | [(3,503) d](/filings/0001213900-25-055793.md) | [(3,548)](/filings/0001213900-25-076594.md) | [(3,766) d](/filings/0001213900-25-110819.md) | [(4,096) d](/filings/0001213900-26-017262.md) | [(4,310) d](/filings/0001213900-26-073223.md) | [(5,372)](/filings/0001213900-26-090301.md) | [(5,411) d](/filings/0001213900-25-110819.md) | [(7,155) d](/filings/0001213900-26-017262.md) | [(5,815) d](/filings/0001213900-26-073223.md) | [(5,972)](/filings/0001213900-26-090301.md) |
| Capital expenditure | $k | [345 d](/filings/0001213900-24-098418.md) | [499 d](/filings/0001213900-25-013462.md) | [483 d](/filings/0001213900-25-055793.md) | [842](/filings/0001213900-25-076594.md) | [161 d](/filings/0001213900-25-110819.md) | [542 d](/filings/0001213900-26-017262.md) | [948 d](/filings/0001213900-26-073223.md) | [934](/filings/0001213900-26-090301.md) | [771 d](/filings/0001213900-25-110819.md) | [1,222 d](/filings/0001213900-26-017262.md) | [1,005 d](/filings/0001213900-26-073223.md) | [688](/filings/0001213900-26-090301.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.3](/filings/0001213900-23-086248.md) | [12.3](/filings/0001213900-24-013348.md) | [17.1](/filings/0001213900-24-068407.md) | [22.4](/filings/0001213900-24-098418.md) | [22.5](/filings/0001213900-25-013462.md) | [33.9](/filings/0001213900-25-076594.md) | [34.3](/filings/0001213900-25-110819.md) | [37.8](/filings/0001213900-26-017262.md) | [1.8](/filings/0001213900-26-090301.md) | [55.6](/filings/0001213900-25-110819.md) | [65.9](/filings/0001213900-26-017262.md) | [5.5](/filings/0001213900-26-090301.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,150,823 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090301.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.